ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 193 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,263,000 | -23.3% | 30,511 | +10.6% | 0.09% | -29.0% |
| Q2 2022 | $1,646,000 | -22.1% | 27,592 | -5.2% | 0.12% | +3.3% |
| Q1 2022 | $2,114,000 | -62.6% | 29,112 | -56.7% | 0.12% | -58.2% |
| Q4 2021 | $5,652,000 | -3.9% | 67,212 | +3.0% | 0.29% | -10.3% |
| Q3 2021 | $5,883,000 | -6.6% | 65,234 | -1.3% | 0.32% | -7.8% |
| Q2 2021 | $6,301,000 | -16.7% | 66,078 | -0.5% | 0.35% | -23.9% |
| Q1 2021 | $7,562,000 | -31.5% | 66,418 | -16.7% | 0.46% | -29.2% |
| Q4 2020 | $11,039,000 | +70.6% | 79,742 | +1.3% | 0.64% | +47.0% |
| Q3 2020 | $6,470,000 | +36.0% | 78,726 | +29.4% | 0.44% | -1.6% |
| Q2 2020 | $4,758,000 | +76.1% | 60,826 | 0.0% | 0.44% | +46.9% |
| Q1 2020 | $2,702,000 | +4.0% | 60,826 | 0.0% | 0.30% | +10.6% |
| Q4 2019 | $2,598,000 | +41.5% | 60,826 | +41.7% | 0.27% | -1.4% |
| Q3 2019 | $1,836,000 | +38.3% | 42,921 | +105.2% | 0.28% | -12.0% |
| Q2 2019 | $1,328,000 | -1.4% | 20,920 | +7.7% | 0.32% | -2.2% |
| Q1 2019 | $1,347,000 | +86.6% | 19,426 | +17.0% | 0.32% | +64.8% |
| Q4 2018 | $722,000 | -43.0% | 16,600 | 0.0% | 0.20% | -50.4% |
| Q3 2018 | $1,267,000 | -64.9% | 16,600 | -64.6% | 0.40% | -37.4% |
| Q2 2018 | $3,610,000 | +16.7% | 46,957 | -22.6% | 0.63% | +13.9% |
| Q1 2018 | $3,093,000 | +7.5% | 60,657 | -2.2% | 0.55% | +1.5% |
| Q4 2017 | $2,878,000 | -79.7% | 62,034 | -76.7% | 0.55% | -41.7% |
| Q3 2017 | $14,194,000 | -12.0% | 266,500 | +2.6% | 0.94% | -12.3% |
| Q2 2017 | $16,130,000 | +15.1% | 259,700 | +25.6% | 1.07% | +17.1% |
| Q1 2017 | $14,011,000 | +18.6% | 206,718 | +23.0% | 0.91% | +10.4% |
| Q4 2016 | $11,813,000 | +6.1% | 168,018 | +7.0% | 0.83% | +5.1% |
| Q3 2016 | $11,138,000 | – | 157,000 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |